Delphinus in Novi Hires Michael Emery as New CFO

Delphinus Medical Technologies, a medical imaging company in Novi, has hired Michael Emery as chief financial officer.
44
Michael Emery // Photo courtesy of Delphinus

Delphinus Medical Technologies, a medical imaging company in Novi, has hired Michael Emery as chief financial officer.

Emery has more than 30 years of experience in financial executive leadership in the pharmaceutical and medical device industries.

“Michael’s strong resume of strategic planning, financial management and building high-performance teams, makes him the ideal leader to help us execute our financial plan here at Delphinus,” says Scott White, CEO of Delphinus. “We are in an exciting time for our organization, where the potential for growth and long-term goal achievement is paramount and requires a financial leader who can position us for success.”

As CFO and COO at Tyber Medical, Emery aligned the company for investment and financial success, streamlined business processes, drove cost reductions and improved efficiencies. Before his role at Tyber, he led financial executive teams at Plasma Surgical and Abbott Pharmaceuticals. His position at Abbott spanned over a decade, where he began at Solvay Pharmaceuticals and carried out multiple financial initiatives, including aligning Solvay for purchase and integrating business operations from Solvay into Abbott. Most recently before joining Delphinus, Emery consulted for multiple companies in the healthcare and medical device space to help strategize and position companies to meet and exceed short and long-term financial goals.

“It is an honor to join a company that is experiencing immense growth as it enters into commercial stage,” says Emery. “The SoftVue system addresses a large gap in the U.S. health care system for women with dense breast tissue, and I look forward to supporting Delphinus’s expansion in the healthcare market and enabling the company to achieve all of its current and future business goals.”

Delphinus Medical Technologies developed SoftVue, an FDA-approved whole breast ultrasound tomography system, to screen women with dense breasts in addition to mammography.